BioCentury
ARTICLE | Distillery Therapeutics

Cancer

November 15, 2016 5:40 PM UTC

Cell culture and mouse studies suggest inhibiting DDX3 in combination with radiation treatment could help treat prostate cancer. In DDX3-expressing human prostate cancer cell lines, shRNA targeting DD...

BCIQ Company Profiles

Johns Hopkins University

BCIQ Target Profiles

DEAD box polypeptide 3 (DDX3)